2026-21881NoticeWallet

Nuclear Medicine Panel Seeks a Practicing Nuclear Pharmacist

Published Date: 10/27/2026

Notice

Summary

The U.S. Nuclear Regulatory Commission is looking for a practicing nuclear pharmacist to join their Advisory Committee on the Medical Uses of Isotopes. If you’re interested, send your nomination by December 28, 2026. This role helps shape important rules and safety guidelines for nuclear medicine, making a real impact on patient care and safety.

Analyzed Economic Effects

7 provisions identified: 4 benefits, 3 costs, 0 mixed.

Time commitment and meeting duties

Selected members must be able to devote approximately 160 hours per year to ACMUI business, attend semi-annual full-day virtual meetings, participate in other teleconferences, and may need to travel to Rockville, MD for the annual ACMUI Commission Briefing Meeting.

Pay and travel reimbursement rules

Members who are not Federal employees are compensated for their service and reimbursed for travel (including per diem) and secretarial and correspondence expenses; full-time Federal employees are reimbursed for travel expenses only.

Nomination opportunity and deadline

The NRC is accepting nominations for the ACMUI Nuclear Pharmacist position. To apply, you must submit an electronic resume or curriculum vitae and a cover letter describing current duties to the contact listed; nominations are due on or before December 28, 2026.

Eligibility and U.S. citizenship required

Nominees must be a currently practicing nuclear pharmacist and must be U.S. citizens. Only candidates meeting those eligibility requirements may be considered for the ACMUI Nuclear Pharmacist position.

Term length and reappointment

ACMUI members currently serve a four-year term and may be considered for reappointment to an additional term.

Security and financial conflict checks required

The selected nominee will undergo a thorough security background check (which may take several weeks to complete) and will be required to complete a financial disclosure statement to avoid conflicts of interest.

Advisory role affects nuclear medicine policy

The ACMUI Nuclear Pharmacist provides advice on regulation of nuclear pharmacy uses of byproduct material, including input on proposed NRC rules and guidance, recommendations on training and experience for Authorized Nuclear Pharmacists, identification of medical events, evaluation of non-routine uses, and bringing community issues to NRC staff.

Personalized for You

How does this regulation affect your finances?

Personalize government policy and PRIA will tell you what this federal register document means for your household, plus every other regulation we track. PRIA reads each provision against your financial profile to show you exactly what matters to your wallet.

Key Dates

Published Date
Effective Date
10/27/2026
12/28/2026

Department and Agencies

Department
Independent Agency
Agency
Nuclear Regulatory Commission
Source: View HTML

Related Federal Register Documents

Previous / Next Documents

Back to Federal Register